September 08, 2020

Strong leadership is critical in redesigning health care—and nurse leaders in particular need to take responsibility for identifying problems and areas of waste, devising and implementing a plan for improvement, tracking this improvement over time, and making necessary adjustments to realize established goals.

September 08, 2020

Nurses have a well-documented history of experiencing compassion fatigue and burnout because of the demands of the profession. The problem may be more pronounced in oncology nurses, who may feel moral distress, grief, and loss related to futility of care or death of a long-term patient.

September 08, 2020

No matter the subspecialty, advanced practice RNs have a significant role in patient treatment and care, but little data exist about their role in radiation oncology. During a presentation at the inaugural ONS Bridge virtual conference, Lorraine Drapek, DNP, FNP-BC, AOCNP®, of Massachusetts General Hospital, and Katie Bukolt, MSN, APRN, NP-C, AOCNP®, of Baylor Charles A. Sammons Cancer Center, discussed the nuances of advanced practice in radiation therapy settings.

September 08, 2020

In February 2019, my colleagues and I published a retrospective analysis of patient-reported satisfaction comparing those who had contact with an oncology nurse navigator (ONN) and those who did not. We analyzed surveys from patients with outpatient oncology infusion or radiation oncology visits in a 24-month period. First, we sorted the surveys into two groups—self-reported ONN contact (n = 315) and self-reported no contact with an ONN (n = 172)—and compared satisfaction.

September 04, 2020

Today’s new normal has changed everything at home, from what we wear to how we teach our children—and in the oncology nursing workplace, from new precautions to the rise of telehealth. It’s also affected nurse residency programs, but one institution has thrived as it adjusted.

September 02, 2020

On September 1, 2020, the U.S. Food and Drug Administration (FDA) designated three of the situations involved in BD’s June 30, 2020, previously announced voluntary recall of several models of its Alaris™ system as class I recalls. Class I recall designation indicates a reasonable probability that the use of the product will cause serious adverse health consequences or death.